Katie is an architect of order. Shielded by Betriebssicherheitsverordnung, she audits with "high-altitude soloing" precision. Using "älskling" as a firewall, she maps the "Oracle Gap" between data and institutional denial.
Sovereign Risk
An analytical audit of Umicore and Li-Cycle's lithium-ion recycling operations, examining how state subsidies and sovereign risk mitigation serve as a strategic institutional moat against foreign refining monopolies.
Cloudflare
A clinical analysis of Cloudflare's traffic classification updates and their structural impact on API management and autonomous maritime logistics.
GlobalFoundries
GlobalFoundries is utilizing a $375 million federal grant to scale post-quantum cryptography hardware. Explore the SEALSQ partnership and the definitive silicon timelines required to secure the domestic supply chain against advanced quantum processors.
IBM
An architectural audit of IBM's post-quantum cryptography migration strategy. Analyzing the capital expenditure of crypto-agility, NIST compliance, and the severe skills gap threatening legacy financial infrastructure.
An objective analysis of ABB's $110 million localized manufacturing expansion and its strategic realignment toward domestic value capture amid surging data center demand.
Intel
A forensic audit of the China Plus One strategy reveals the operational friction and capital expenditure required as Intel and Samsung attempt to establish a multipolar semiconductor supply chain.
Foxconn / TSMC
Forensic audit of Foxconn / TSMC under Multipolar Supply.
Katie defends Google and Arqit's AI grid management and quantum encryption as essential load balancing tools to prevent catastrophic blackouts amid global supply chain bottlenecks.
Nexans
An analytical review of Nexans' strategic positioning in global grid modernization. We examine their €7.9 billion backlog, Q1 2026 organic growth in Electrification, and the institutional solvency mechanisms driving infrastructure capital expenditure.
Eaton
Katie analyzes Eaton's corporate pivot to software-defined power, examining how AI and predictive modeling offer immediate financial triage for an aging electrical grid.
Exact Sciences
An objective analysis of Exact Sciences' $21 billion acquisition by Abbott Laboratories, examining the gap between precision oncology revenue and liquid biopsy reimbursement hurdles.
Natera
An audit of Natera's Signatera assay and the structural realities of precision oncology. Examining the clinical infrastructure of molecular residual disease detection versus the limitations of healthcare reimbursement models.